Page 3 - HFA Dateline 2020-2021 Special Issue
P. 3

IN THIS ISSUE



                                                 ARTICLES




         Assisting, educating, and advocating    COVID-19 Vaccines
                  for the bleeding disorders     & Emerging Therapies
                     community since 1994.

        Volume 22 • Issue 1 • Special Issue 2021  Informed Consent:
                                                 A Process, Not
                  EXECUTIVE LEADERSHIP
                 Board Chair • Allie Ritchey     Just A Form
               President & CEO • Dr. Sharon
                             Meyers, CFRE
                                                              FDA's Gene
                      PRODUCTION TEAM                          and Cell Therapy
                    Editor • Kyle McKendall
           Design & Layout • Ashley Williams                     Framework
              Proofreader • Melanie Padgett
                                   Powers
                                                 Drug Recall
                      Contributing Writers
                  Michael Bishop, HFA Staff      Process & Recent
                            Dr. David Clark      Product Recalls
                           Dr. Lisa Hensley
                   Angela N. Johnson, PH.D
                       Lori Long, HFA Staff      Drug Approval Process
              Emily Roush-Bobolz, HFA Staff
                     Sonji Wilkes, HFA Staff
                    The information printed in     Clinical Studies:
                Dateline Federation is provided     How Do They
              for general purpose use. HFA does     Work?
              not give medical advice or engage
                 in the practice of medicine and
          recommends that you consult with your
              physician or local treatment center
         before beginning any form of treatment.
             Requests for permission to translate
                 or reprint contents of Dateline                       FEATURES
               Federation should be directed to
                      info@hemophiliafed.org.
                                                   Current
             999 N. Capitol Street NE • Suite 301
                       Washington, DC 20002        Products
                              202.675.6984
                      info@hemophiliafed.org       for Treament

        ©2021 Hemophilia Federation of America.                                                   Emerging
                          All rights reserved.
                                                                                                  Therapies

                Connect with us on social media                                                Undergoing
              for daily posts and updates about                                              Clinical Trails
                     what’s happening at HFA.


                                                                                             SPECIAL ISSUE 2021         3
   1   2   3   4   5   6   7   8